Antithrombotic medications and the etiology of intracerebral hemorrhage MUCH-Italy

Neurology

Volumn 82, Issue 6, 2014, Pages 529-535

  Pezzini, Alessandro ^a   Grassi, Mario ^c   Paciaroni, Maurizio ^d   Zini, Andrea ^e   Silvestrelli, Giorgio ^f   Zotto, Elisabetta Del ^g   Caso, Valeria ^d   Dell'Acqua, Maria Luisa ^e   Giossi, Alessia ^h   Volonghi, Irene ^h   Simone, Anna Maria ^e   Lanari, Alessia ^f   Costa, Paolo ^a   Poli, Loris ^a   Morotti, Andrea ^a   De Giuli, Valeria ^a   Pepe, Daniele ^c   Gamba, Massimo ⁱ   Ciccone, Alfonso ^g   Ritelli, Marco ^b   Colombi, Marina ^b   Agnelli, Giancarlo ^d   Padovani, Alessandro ^a   more..

^a Dipartimento di Scienze Cliniche e Sperimentali Clinica Neurologica Divisione di Biologia e Genetica   (Japan)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

^e Nuovo Ospedale S Agostino   (Italy)

^f Uonpia Ospedale C Poma Mantova   (Italy)

^g UO di Recupero e Rieducazione Funzionale IRCCS Fondazione Don Gnocchi   (Italy)

^h Azienda Ospedaliero Universitaria Pisana   (Italy)

ⁱ Stroke Unit   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

AGED; AGING; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN REGION; DOSE RESPONSE; FEMALE; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BASAL GANGLIA HEMORRHAGE; BRAIN; BRAIN STEM; CEREBELLUM; CEREBRAL CORTEX; CEREBRAL HEMORRHAGE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; HYPERTENSION; ITALY; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; THALAMUS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84895771108     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000108     Document Type: Article

References (23)

1. Lauer A, Pfeischifter W, Schaffer CB, Lo EH, Foerch C. Intracerebral haemorrhage associated with antithrombotic treatment: Translational insights from experimental studies. Lancet Neurol 2013;12:394-405.
2. He J, Whelton PK, Vu B, Klag MJ. Aspirin and risk of hemorrhagic stroke: A meta-analysis of randomized controlled trials. JAMA 1998;280:1930-1935.
3. Huhtakangas J, Tetri S, Juvela S, et al. Effect of increased warfarin use on warfarin-related cerebral haemorrhage: A longitudinal population-based study. Stroke 2011;42: 2431-2435.
4. Flaherty ML, Kissela B, Woo D, et al. The increasing incidence of anticoagulant-associated intracerebral haemorrhage. Neurology 2007;68:116-121.
5. Buresly K, Eisenberg M, Zhang X, et al. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction. Arch Intern Med 2005;165: 784-789.
6. Chimowitz M, Lynn M, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305-1316.
7. Lipton RB, Berger AR, Lesser ML, Lantos G, Portenoy RK. Lobar vs thalamic and basal ganglion haemorrhage: Clinical and radiographic features. J Neurol 1987;234:86-90.
8. Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral haemorrhage. Arch Intern Med 2004;164:880-884.
9. Cucchiara B, Messe S, Sansing L, Kasner S, Lyden P; for the CHANT Investigators. Hematoma growth in oral anticoagulant related intracerebral hemorrhage. Stroke 2008;39;2993-2996.
10. Maas MB, Rosenberg NF, Kosteva AR, Prabhakaran S, Naidech AM. Coagulopathy disproportionately predisposes to lobar intracerebral hemorrhage. Neurocrit Care 2013;18:166-169.
11. Flaherty ML, Haverbusch M, Sekar P, et al. Location and outcome of anticoagulant-associated intracerebral hemorrhage. Neurocrit Care 2006;5:197-201.
12. Dequatre-Ponchelle N, Hénon H, Pasquini M, et al. Vitamin K antagonists-associated cerebral hemorrhages: What are their characteristics? Stroke 2013;44:350-355.
13. Pezzini A, Grassi M, Paciaroni M, et al Multicentre Study on Cerebral Hemorrhage in Italy (MUCH-Italy) Investigators. Obesity and the risk of intracerebral hemorrhage: The Multicentre Study on Cerebral Hemorrhage in Italy. Stroke 2013;44:1584-1589.
14. Lang EW, Ren Ya Z, Preul C, et al. Stroke pattern interpretation: The variability of hypertensive versus amyloid angiopathy hemorrhage. Cerebrovasc Dis 2001;12: 121-130.
15. Flaherty ML, Tao H, Haverbusch M, et al. Warfarin use leads to larger intracerebral hematomas. Neurology 2008; 71:1084-1089.
16. Biffi A, Battey TWK, Ayres AM, et al. Warfarin-related intraventricular hemorrhage: Imaging and outcome. Neurology 2011;77:1840-1846.
17. Attems J. Sporadic cerebral amyloid angiopathy: Pathology, clinical implications, and possible pathomechanisms. Acta Neuropathol 2005;110:345-359.
18. Revesz T, Ghiso J, Lashley T, et al. Cerebral amyloid angiopathies: A pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol 2003;62:885-898.
19. Nicoll JA, Burnett C, Love S, et al. High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 1997;41: 716-721.
20. Biffi A, Halpin A, Towfighi A, et al. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology 2010;75:693-698.
21. Melo TP, Bogousslavsky J, Regli F, Janzer R. Fatal hemorrhage during anticoagulation of cardioembolic infarction: Role of cerebral amyloid angiopathy. Eur Neurol 1993;33:9-12.
22. McCarron MO, Nicoll JA. Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage. Lancet Neurol 2004;3:484-492.
23. Greenberg SM, Vernooij MW, Cordonnier C, et al; for the Microbleed Study Group. Cerebral microbleeds: A guide to detection and interpretation. Lancet Neurol 2009;8:165-174.